The medical health industry is an excellent example of where devices and digital technologies have been adopted to work alongside drug formulation to support optimal patient outcomes.
Everyday examples of this include drug-eluting stents for management of cardiovascular disease and device technology to support patients in managing diabetes.
This approach unburdens the patient, addressing behavioural factors such as poor compliance and automatically adapting to the real-time needs of the patient. This provides an excellent, and transferable, example of device and digital combos working in conjunction with formulations to support optimised outcomes for the user.
Here, we map this approach to similar challenges in the beauty industry, supporting consumers to achieve product results that have been confirmed through clinical trials.